Literature DB >> 30481134

Use of Telehealth Screening to Detect Diabetic Retinopathy and Other Ocular Findings in Primary Care Settings.

Xinxiao Gao1,2, Carl H Park1, Krista Dedrick1, Durga S Borkar1, Anthony Obeid1, Shae Reber1, Jay Federman1.   

Abstract

Purpose: To determine the incidence of diabetic retinopathy (DR) and other ocular findings in previously diagnosed diabetes using telehealth retinal screening with nonmydriatic fundus photography (nFP) in primary care physicians' offices.
Methods: A retrospective study based on electronic chart review was performed. All diabetic patients who participated in the Wills Eye Hospital (WEH) telehealth retinal screening program from July 1, 2012 to February 20, 2017 were included. In addition to evaluation of DR, other eye pathologies of the retina were detected using nFP.
Results: Overall, 9,946 diabetics participated in the WEH telehealth screening system. After exclusion of missing or unreadable images, 15,180 eyes of 7,624 (76.7%) patients were eligible for final analysis. A total of 1,269 (16.6%) patients were noted to have DR changes in at least one eye. Of those, 475 (37.4%) had mild nonproliferative DR (NPDR) in the more severely affected eye, 712 (56.1%) had moderate NPDR, 33 (2.6%) had severe NPDR, 19 (1.5%) had proliferative DR, and 30 (2.4%) have received pan-retinal photocoagulation previously. In addition, there was evidence of diabetic macular edema detectable on nFP in 34 eyes of 29 patients. Other ocular findings included hypertensive retinopathy (709, 9.3%), increased or asymmetric cup-to-disc ratio (562, 7.4%), age-related cataract (379, 5.0%), cotton-wool spots (221, 2.9%), choroidal nevus (74, 1.0%), age-related macular degeneration (AMD) (66, 0.9%), and epiretinal membrane (48, 0.6%). Patients with hypertensive retinopathy, glaucomatous findings, cataract, or AMD were significantly older (p < 0.001) than those without these ocular pathologies.
Conclusion: The WEH Telehealth Screening Program identified DR in approximately one out of six patients and other ocular pathologies in over 25% of the diabetic population that received screenings in Philadelphia area primary care offices. Given the importance of early detection and routine eye care to prevent vision loss for DR patients, these findings have a significant impact.

Entities:  

Keywords:  diabetic retinopathy; ocular pathology; screening; telehealth

Year:  2018        PMID: 30481134     DOI: 10.1089/tmj.2018.0016

Source DB:  PubMed          Journal:  Telemed J E Health        ISSN: 1530-5627            Impact factor:   3.536


  5 in total

Review 1.  Hypertensive eye disease.

Authors:  Carol Y Cheung; Valérie Biousse; Pearse A Keane; Ernesto L Schiffrin; Tien Y Wong
Journal:  Nat Rev Dis Primers       Date:  2022-03-10       Impact factor: 52.329

2.  Evaluation of an OCT-AI-Based Telemedicine Platform for Retinal Disease Screening and Referral in a Primary Care Setting.

Authors:  Xiaoqiang Liu; Chun Zhao; Lilong Wang; Guanzheng Wang; Bin Lv; Chuanfeng Lv; Guotong Xie; Fang Wang
Journal:  Transl Vis Sci Technol       Date:  2022-03-02       Impact factor: 3.283

3.  Automated diabetic retinopathy screening for primary care settings using deep learning.

Authors:  Alauddin Bhuiyan; Arun Govindaiah; Avnish Deobhakta; Mohd Hossain; Richard Rosen; Theodore Smith
Journal:  Intell Based Med       Date:  2021-11-20

4.  Implementation and sustainment of a statewide telemedicine diabetic retinopathy screening network for federally designated safety-net clinics.

Authors:  Ana Bastos de Carvalho; S Lee Ware; Feitong Lei; Heather M Bush; Robert Sprang; Eric B Higgins
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240

Review 5.  Multispecialty Enterprise Imaging Workgroup Consensus on Interactive Multimedia Reporting Current State and Road to the Future: HIMSS-SIIM Collaborative White Paper.

Authors:  Christopher J Roth; David A Clunie; David J Vining; Seth J Berkowitz; Alejandro Berlin; Jean-Pierre Bissonnette; Shawn D Clark; Toby C Cornish; Monief Eid; Cree M Gaskin; Alexander K Goel; Genevieve C Jacobs; David Kwan; Damien M Luviano; Morgan P McBee; Kelly Miller; Abdul Moiz Hafiz; Ceferino Obcemea; Anil V Parwani; Veronica Rotemberg; Elliot L Silver; Erik S Storm; James E Tcheng; Karen S Thullner; Les R Folio
Journal:  J Digit Imaging       Date:  2021-06-15       Impact factor: 4.056

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.